Karo Healthcare has acquired Perrigo’s Dermacosmetics portfolio, enhancing its presence in the skincare market and entering the fast-growing Polish consumer health sector with a projected annual revenue increase of over €120 million.

Target Company Overview

Karo Healthcare has confirmed its acquisition of Perrigo's Dermacosmetics portfolio, which encompasses a range of well-regarded skin health brands. This portfolio includes distinguished names such as ACO, with sub-brands including Cosmica, Canoderm, Cliniderm, and Miniderm, as well as Biodermal, Emolium, and Iwostin. These brands are recognized for their strong market presence and endorsements from healthcare professionals, contributing to a collective annual revenue of over €120 million across Northern Europe, the Netherlands, and Poland.

This acquisition marks a significant milestone for Karo Healthcare, following its takeover by KKR, as it aims to bolster its position as a leading player in the European consumer healthcare sector. With the closing expected in the first quarter of 2026, Karo is set to enhance its operational capabilities and brand portfolio, enabling a more extensive reach in the competitive skincare market.

Industry Overview in Target Country

The consumer healthcare industry in Northern Europe has been witnessing rapid growth, driven by increasing consumer awareness regarding skin health, premium skincare products, and an overall rise in heal